BioSpace News Archive

Drug Development

NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain

Pivotal Phase III study will further evaluate the efficacy of candidate NB-01 on pain associated with diabetic neuropathy

January 8, 2019
·
4 min read
Deals

Generex Biotechnology Completes Acquisition of Olaregen Therapeutix Inc.

Closes transaction to complete 51% acquisition of Olaregen Therapeutix Plans Commercial Launch of FDA-cleared Excellagen®

January 8, 2019
·
6 min read
Global Biotechnology Reagents Market 2019-2023| Increasing R&D Investments to Drive Growth| Technavio

The global biotechnology reagents market research report by Technavio predicts the market to post a CAGR of close to 9% during the period 2019-2023

January 8, 2019
·
4 min read
ENT Surgical Lasers Demand Influenced by Shift from Traditional Model to Care Delivery Model

The ENT surgical devices market witnessed a steady progress and grew at 6.6% y-o-y in 2018.

January 8, 2019
·
3 min read
Pharm Country

AbleTo Announces Strategic Investment from Optum Ventures

Funding marks the beginning of a relationship aligned around behavioral health innovation

January 8, 2019
·
3 min read
Genetown

The National Institute of Whole Health offers New Credential Options for Nurses

NEW OPTION FOR LICENSED NURSES

January 8, 2019
·
2 min read
Pharm Country

Nanit Unveils Breathing Wear™ at CES 2019

Newest Innovation for Parents Uses Computer Vision Technology to Monitor Baby’s Breathing Motion, Without Putting Electronics on the Baby

January 8, 2019
·
4 min read
Deals

Prescience Point Capital Management Issues Positive Report on MiMedx Group Inc. (OTC: MDXG)

Believes stock is worth at least four times current trading levels

January 8, 2019
·
5 min read
‘Enjoyable forms’ to see major contract services growth in 2019

Demand in China driven by emerging consumer demand, but in the USA and EU growth triggered by market maturation

January 8, 2019
·
4 min read
Pharm Country

ANGELO GORDON’S TWIN BROOK CAPITAL PARTNERS COMMITS OVER $2 BILLION TO PRIVATE EQUITY-BACKED HEALTHCARE TRANSACTIONS

Over $1 Billion Deployed to Healthcare Transactions in 2018

January 8, 2019
·
3 min read